Icon

INCRUSE ELLIPTA (nda205382)- (EQ 0.0625MG BASE/INH)

UMECLIDINIUM BROMIDE GLAXO GRP ENGLAND
EQ 0.0625MG BASE/INH
No No
2030-Oct-11 2018-Dec-18
None None
None No
INCRUSE ELLIPTA is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 0.0625MG BASE/INH ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.